[HTML][HTML] Bone circuitry and interorgan skeletal crosstalk

M Zaidi, SM Kim, M Mathew, F Korkmaz, F Sultana… - Elife, 2023 - elifesciences.org
The past decade has seen significant advances in our understanding of skeletal
homeostasis and the mechanisms that mediate the loss of bone integrity in disease. Recent …

Osteoporosis: an update on screening, diagnosis, evaluation, and treatment

SA Sabri, JC Chavarria, C Ackert-Bicknell… - …, 2023 - journals.healio.com
Osteoporosis screening, diagnosis, and treatment have gained much attention in the health
care community over the past 2 decades. During this time, creation of multispecialty …

Generic platform for the multiplexed targeted electrochemical detection of osteoporosis-associated single nucleotide polymorphisms using recombinase polymerase …

M Ortiz, M Jauset-Rubio, O Trummer, I Foessl… - ACS Central …, 2023 - ACS Publications
Osteoporosis is a multifactorial disease influenced by genetic and environmental factors,
which contributes to an increased risk of bone fracture, but early diagnosis of this disease …

Identification of four-gene signature to diagnose osteoarthritis through bioinformatics and machine learning methods

Z Chen, W Wang, Y Zhang, Y Hua - Cytokine, 2023 - Elsevier
Background Although osteoarthritis (OA) is one of the most prevalent joint disorders,
effective biomarkers to diagnose OA are still unavailable. This study aimed to acquire some …

SP7: From bone development to skeletal disease

JS Wang, N Tokavanich, MN Wein - Current osteoporosis reports, 2023 - Springer
Abstract Purpose of Review The purpose of this review is to summarize the different roles of
the transcription factor SP7 in regulating bone formation and remodeling, discuss current …

Lowering of circulating sclerostin may increase risk of atherosclerosis and its risk factors: evidence from a genome‐wide association meta‐analysis followed by …

J Zheng, E Wheeler, M Pietzner… - Arthritis & …, 2023 - Wiley Online Library
Objective In this study, we aimed to establish the causal effects of lowering sclerostin, target
of the antiosteoporosis drug romosozumab, on atherosclerosis and its risk factors. Methods …

Twelve Loci associated with bone density in middle-aged and elderly Chinese: the Shanghai Changfeng study

H Zeng, J Ge, W Xu, H Ma, L Chen, M Xia… - The Journal of …, 2023 - academic.oup.com
Context Previous genome-wide association studies (GWASs) of bone mineral density (BMD)
were mainly conducted in Europeans. Objective To explore genetic variants that affect BMD …

Suppression of TLR4 prevents diabetic bone loss by regulating FTO-mediated m6A modification

X Shen, C Lan, Y Lin, F Zhang, Y Zhang… - International …, 2023 - Elsevier
Abstract Toll-like receptor-4 (TLR4) has been implicated in the development and
progression of diabetic osteoporosis. However, the mechanisms underlying TLR4-regulated …

[HTML][HTML] Bone Trans-omics: Integrating Omics to Unveil Mechanistic Molecular Networks Regulating Bone Biology and Disease

BH Mullin, ABP Ribet, NJ Pavlos - Current Osteoporosis Reports, 2023 - Springer
Abstract Purpose of Review Recent advancements in “omics” technologies and
bioinformatics have afforded researchers new tools to study bone biology in an unbiased …

Discovery of potential biomarkers for osteoporosis diagnosis by individual omics and multi-omics technologies

J Yang, J Wu - Expert Review of Molecular Diagnostics, 2023 - Taylor & Francis
Introduction Global aging has made osteoporosis an increasingly serious public health
problem. Osteoporotic fractures seriously affect the quality of life of patients and increase …